LGALS1 and pancreatic ductal adenocarcinoma: Galectin-1, a salient member of the galectin family, has been identified as a vital modulator of multiple signaling pathways contributing to the progression of pancreatic ductal adenocarcinoma [67,68,70,73,79,80,81,82].